CBS' long-running cop drama Blue Bloods will be ending after its upcoming 14th season. The final season will consist of 18 episodes divided into two parts, with the first 10 episodes premiering on February 16, 2024, and the remaining 8 episodes airing in fall 2024.
This extended farewell is being given to two of CBS' top series that are coming to an end, with the final season of Young Sheldon also being expanded. Blue Bloods, which stars Tom Selleck, has been a strong performer for CBS throughout its run.
CBS executives Amy Reisenbach and David Stapf praised Blue Bloods and its cast, as well as the late executive producer Leonard Goldberg and writer/executive producer Kevin Wade.
The decision to end Blue Bloods came after difficult negotiations earlier this year, during which CBS asked for significant budget cuts. The cast and producers agreed to salary reductions to keep the show going and preserve jobs for the crew. The writers began crafting the upcoming season as a potential final chapter, and the decision to split the season into two parts was made after the end of the SAG-AFTRA strike.
Blue Bloods has been a strong performer for CBS on multiple platforms, including streaming and syndication. It is one of the top 10 series on Paramount+ based on minutes viewed and has also performed well on Pluto TV. Executive producer Kevin Wade expressed gratitude for the show's dedicated fan base and looked forward to delivering an emotionally satisfying final season. Tom Selleck, who has led the cast of Blue Bloods, expressed gratitude for the opportunity to work on the show for the past 13 years.
The series has celebrated the importance of family and the men and women who protect and serve in New York City. Selleck thanked CBS for their support and the fans who have watched the show every Friday night. Blue Bloods has been a significant asset for CBS over the past decade and a half, with strong performances domestically and internationally. The show has resonated with millions of viewers and will leave behind a lasting legacy.